News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Dr. Evan Manolis Joins AcronGenomics Inc.'s Board of Directors
May 8, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
GENEVA, Switzerland--(BUSINESS WIRE)--Acrongenomics Inc. (OTCBB:AGNM) a publicly traded life sciences company today announced that Dr. Evan Manolis has joined its board of directors and scientific committee.
Twitter
LinkedIn
Facebook
Email
Print
People
Europe
MORE ON THIS TOPIC
Layoffs
BioAtla Axes 70% of Staff, Explores Strategic Options
March 2, 2026
·
1 min read
·
Angela Gabriel
IPO tracker
Generate Clocks Largest IPO Since 2024 With $400M Raise
February 27, 2026
·
5 min read
·
Tristan Manalac
Special edition
Deep Dive: BioSpace Takes On JPM26 in San Francisco
February 27, 2026
·
2 min read
·
Annalee Armstrong
Earnings
After Sarepta’s Annus Horribilis, Elevidys Sales Expected To Continue Downward Spiral
February 26, 2026
·
5 min read
·
Annalee Armstrong
